ReviewCureus2025
The Role of Machine Learning in Predicting Hospital Readmissions Among General Internal Medicine Patients: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Digital Health Revolution in Saudi Arabia: A Narrative Review of Healthcare Transformation.Healthcare (Basel, Switzerland) · 2026Review
- Nurse-Led Large Language Model Chatbot for Predicting and Preventing Complications After Coronary Artery Bypass Grafting: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2026Article
- Prediction of 30-Day All-Cause Hospital Readmissions Using Limited Structured Electronic Health Record Data: Retrospective Comparative Study.JMIR formative research · 2026Article
- Machine learning using PROFUND components for 30-day readmission prediction in multimorbid patients: a prospective multicentre study.Scientific reports · 2026Article
- Leveraging a machine learning model to predict hospital readmission risk: integrating clinical and social determinants of health data.Frontiers in public health · 2026Article
- Biomarkers in Heart Failure: A Review and a Wish.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hospital readmissions contribute significantly to healthcare costs. While traditional regression models for predicting 30-day readmission risk offer modest accuracy, machine learning (ML) presents an opportunity to capture complex relationships in healthcare data, potentially enhancing predictions. This review assesses the role of ML in predicting 30-day readmissions for general internal medicine admissions in the U.S. Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, a literature search of PubMed (2014-2023) was conducted using the keywords "artificial intelligence," "machine learning," and "readmission." The review focused on ML models predicting readmissions in general internal medicine patients in the U.S. Nine studies were reviewed, covering conditions like acute myocardial infarction (AMI), heart failure (HF), pneumonia (PNA), chronic obstructive pulmonary disease (COPD), and other general internal medicine cases. ML models such as artificial neural networks (ANN), random forests (RF), gradient boosting, logistic regression, and natural language processing (NLP) were used. ANN and RF models outperformed traditional regression methods, while NLP-based approaches showed limited success. Subgroup modeling provided marginal improvements in predictive accuracy. In conclusion, ML offers significant potential for improving 30-day readmission predictions by overcoming the limitations of traditional models. ANN and RF are particularly effective in predicting readmissions in general internal medicine. To advance predictive capabilities, future research should refine NLP, subgroup modeling, and focus on model generalizability, integration of diverse data sources, and the development of explainable AI for clinical adoption. Addressing these challenges could transform healthcare delivery, improve patient outcomes, and reduce costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.